Hinge Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	587.86	390.4	292.73
Revenue Growth (YoY)	50.58%	33.37%	-
Cost of Revenue	119.64	90.5	98.55
Gross Profit	468.22	299.9	194.18
Selling, General & Admin	646.46	230.97	214.64
Research & Development	368.14	100.84	110.06
Total Operating Expenses	1,015	331.81	324.69
Operating Income	-546.37	-31.91	-130.51
Total Non-Operating Income (Expense)	19.11	20.65	21.97
Pretax Income	-527.26	-11.26	-108.55
Provision for Income Taxes	1	0.68	-0.41
Net Income	-424.09	-11.93	-108.14
Net Income Attributable to Preferred Dividends	-104.17	-	-
Net Income to Common	-424.09	-11.93	-108.14
Shares Outstanding (Basic)	55	14	13
Shares Outstanding (Diluted)	55	14	13
Shares Change (YoY)	302.55%	4.16%	-
EPS (Basic)	-7.77	-0.88	-8.31
EPS (Diluted)	-7.77	-0.88	-8.31
Free Cash Flow	170.73	47.96	-65.89
Free Cash Flow Growth	255.97%	-	-
Free Cash Flow Per Share	3.13	3.54	-5.06
Gross Margin	79.65%	76.82%	66.33%
Operating Margin	-92.94%	-8.17%	-44.59%
Profit Margin	-89.86%	-3.06%	-36.94%
FCF Margin	29.04%	12.29%	-22.51%
EBITDA	-541.24	-25.96	-124.89
EBITDA Margin	-92.07%	-6.65%	-42.66%
EBIT	-546.37	-31.91	-130.51
EBIT Margin	-92.94%	-8.17%	-44.59%
Effective Tax Rate	-0.19%	-6.01%	0.37%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q